United States Pharmaceutical Intermediates Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global "Pharmaceutical Intermediates Market" is estimated to reach at a CAGR of 4% during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In October 2025, Cambrex Corporation announced a USD 120 million investment to expand its manufacturing operations in Charles City, Iowa. The project focuses on boosting production capacity for APIs and pharmaceutical intermediates, enhancing U.S. drug supply resilience and domestic manufacturing capabilities.

✅ In June 2025, Piramal Pharma Solutions committed a USD 90 million expansion of its Lexington, Kentucky and Riverview, Michigan facilities. The investment targets increased capacity for sterile injectables, high-potency APIs, and pharmaceutical intermediates to support complex therapy development.

✅ In March 2025, the U.S. pharmaceutical intermediates sector witnessed strong growth momentum driven by the reshoring of drug manufacturing and rising outsourcing activities to contract development and manufacturing organizations (CDMOs). The trend reflects growing emphasis on domestic production security.

✅ In February 2025, industry projections indicated sustained growth for the global pharmaceutical intermediates market, supported by increased R&D investments and regulatory incentives for local manufacturing. The outlook highlights continued expansion in U.S. intermediate production capabilities.

Japan: Recent Industry Developments

✅ In June 2025, ITOCHU Corporation launched a strategic support service for overseas pharmaceutical firms entering Japan. The initiative enhances collaboration in drug development and manufacturing by improving access to intermediates, APIs, and regulatory infrastructure.

✅ In April 2025, Marubeni Corporation acquired a 60% stake in a new company formed to manage the Asian pharmaceuticals business of Sumitomo Pharma Co., Ltd. The partnership strengthens regional production and supply of APIs and intermediates across Asia and Japan.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pharmaceutical-intermediates-market?sb

Key Players:

=> Aceto Corporation, BASF SE, Chiracon GmbH, Yin-sheng Biotech Co., Ltd., Dishman Group, Green Vision Life Sciences, Midas Pharma GmbH, Sanofi SA, Vertellus Holdings LLC., among others.

Growth Forecast Projected:

The Global Pharmaceutical Intermediates Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Pharmaceutical Intermediates Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-intermediates-market

Key Segments:

➥ By Type: Chemical Intermediate, Bulk Drug Intermediate (Chiral Intermediates, Achiral Intermediates), Custom Intermediates, Others
➥ By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Others
➥ By End-User: Biotech and Pharma Companies, Research Institutions, Contract Manufacturing Organizations, Others

Regional Analysis for Pharmaceutical Intermediates Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Pharmaceutical Intermediates producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Pharmaceutical Intermediates revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmaceutical-intermediates-market?sb

FAQ

Q: What is the growth rate of the Pharmaceutical Intermediates Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 4% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.